Evidence map›Paper›PMID 38481649›Full record

ArticleCanada communicable disease report = Releve des maladies transmissibles au Canada2023

Current and future burden from Lyme disease in Québec as a result of climate change.

Marion Ripoche, Alexandra Irace-Cima, Ariane Adam-Poupart, Geneviève Baron, Catherine Bouchard, Alex Carignan, François Milord, Najwa Ouhoummane, Pierre A Pilon, Karine Thivierge and 2 more

Abstract read
In one paragraph

Article in Canada communicable disease report = Releve des maladies transmissibles au Canada, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Marion RipocheInstitut national de la santé publique du Québec, Montréal, QC.
Alexandra Irace-CimaInstitut national de la santé publique du Québec, Montréal, QC.
Ariane Adam-PoupartInstitut national de la santé publique du Québec, Montréal, QC.
Geneviève BaronDirection de la santé publique de l'Estrie [Estrie Public Health Department], CIUSSS de l'Estrie-CHUS, Sherbrooke, QC.
Catherine BouchardPublic Health Agency of Canada, Saint-Hyacinthe, QC.
Alex CarignanUniversité de Sherbrooke, Sherbrooke, QC.
François MilordDirection de Santé Publique de la Montérégie [Montérégie Public Health Department], CISSS de la Montérégie-Centre, Longueuil, QC.
Najwa OuhoummaneInstitut national de la santé publique du Québec, Montréal, QC.
Pierre A PilonDirection de Santé Publique de Montréal [Montréal Public Health Department], Montréal, QC.
Karine ThiviergeInstitut national de la santé publique du Québec, Montréal, QC.
Kate ZinszerUniversité de Montréal, Montréal, QC.
Diane ChaumontOuranos, Montréal, QC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Context: Environmental changes will foster the spread of Methods: Cases of Lyme disease reported in Québec from 2015 to 2019 were used to describe their demographic, geographical and clinical characteristics and the cost of their initial care. Three incidence rate scenarios were then developed to estimate the number of cases expected by 2050, based on demographic and climate projections. Results: From 2016 to 2019, 1,473 cases of Lyme disease were reported in Québec. Over 90% of those cases were acquired in two regions of southern Québec (Estrie and Montérégie), while the individuals infected were residents from all over Québec. The average age of cases is 44 years and 66% of infections were at the localized stage, the first stage of Lyme disease. The cost of initial care is estimated at an average of $182 CAN per patient ($47 CAN at the localized stage and $443 CAN at the disseminated stage). According to projections, over 95% of the Québec population will live in a climate zone conducive to the establishment of ticks by 2050, with a number of cases acquired in Québec being 1.3 to 14.5 times higher than in 2019, depending on the incidence rate scenario used. Conclusion: The epidemiological burden is concentrated primarily in southern Québec, but the clinical and economic burden is already distributed throughout the province. The projections for 2050 should help the regions of Québec adapt and optimize public health protection measures.

Indexed as

Borrelia burgdorferiburdenclimate changeLyme diseasetick-borne illness

Identifiers

PMID38481649
PMCPMC10937046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.